- Home
- KALA vs PSHG Comparison
KALA vs PSHG Comparison
Compare KALA & PSHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- PSHG
- Stock Information
- Founded
- KALA 2009
- PSHG 2010
- Country
- KALA United States
- PSHG Greece
- Employees
- KALA N/A
- PSHG N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- PSHG Marine Transportation
- Sector
- KALA Health Care
- PSHG Consumer Discretionary
- Exchange
- KALA Nasdaq
- PSHG Nasdaq
- Market Cap
- KALA 26.2M
- PSHG 25.2M
- IPO Year
- KALA 2017
- PSHG N/A
- Fundamental
- Price
- KALA $0.81
- PSHG $2.00
- Analyst Decision
- KALA Buy
- PSHG
- Analyst Count
- KALA 3
- PSHG 0
- Target Price
- KALA $31.50
- PSHG N/A
- AVG Volume (30 Days)
- KALA 1.3M
- PSHG 125.6K
- Earning Date
- KALA 11-07-2025
- PSHG 11-07-2025
- Dividend Yield
- KALA N/A
- PSHG N/A
- EPS Growth
- KALA N/A
- PSHG 5.84
- EPS
- KALA N/A
- PSHG 1.56
- Revenue
- KALA N/A
- PSHG $84,042,000.00
- Revenue This Year
- KALA N/A
- PSHG N/A
- Revenue Next Year
- KALA N/A
- PSHG $17.95
- P/E Ratio
- KALA N/A
- PSHG $1.29
- Revenue Growth
- KALA N/A
- PSHG N/A
- 52 Week Low
- KALA $0.77
- PSHG $1.31
- 52 Week High
- KALA $20.60
- PSHG $2.34
- Technical
- Relative Strength Index (RSI)
- KALA 26.24
- PSHG 59.12
- Support Level
- KALA $0.77
- PSHG $1.98
- Resistance Level
- KALA $1.52
- PSHG $2.16
- Average True Range (ATR)
- KALA 0.10
- PSHG 0.09
- MACD
- KALA 0.31
- PSHG 0.01
- Stochastic Oscillator
- KALA 4.56
- PSHG 51.69
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About PSHG Performance Shipping Inc.
Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates six Aframax tanker vessels.